COVID-19

381 bookmarks
Newest
Rising Risks with COVID Reinfection | Harvard Magazine
Rising Risks with COVID Reinfection | Harvard Magazine
Assistant professor of medicine Amy Barczak shared a Nature study that used data from the Veteran’s Administration to assess the cumulative risk of post-infection effects in people with one, two, and three or more SARS-CoV-2 infections, as compared to noninfected controls. The data show a consistent pattern of increased likelihood of hospitalization, cardiovascular effects, clotting and other blood disorders, diabetes, fatigue, gastrointestinal distress, kidney damage, mental health effects such as depression, musculoskeletal damage, neurological deficits, and pulmonary damage with each episode. Prior infection does not change the course of disease in subsequent infections, just the risk of severe complications.
Rising Risks with COVID Reinfection | Harvard Magazine
How COVID-19 alters the immune system
How COVID-19 alters the immune system
COVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say researchers. This could affect responses to secondary infections.
How COVID-19 alters the immune system
How your first brush with COVID warps your immunity
How your first brush with COVID warps your immunity
Nature - The immune system responds more strongly to the strain of a virus that it first met, weakening response to other strains. Can this ‘imprinting’ be overcome?
How your first brush with COVID warps your immunity
Analysis reveals global post-covid surge in infectious diseases
Analysis reveals global post-covid surge in infectious diseases
A large post-covid global surge in common communicable diseases including influenza, measles, tuberculosis, and whooping cough has been identified in a new analysis of data from 60 organisations and public health agencies. Since the beginning of 2022, 44 countries have experienced a 10-fold increase in the incidence of at least one of 13 infectious diseases compared with a pre-pandemic baseline, according to the analysis1 by the UK based disease forecasting firm Airfinity and the US news website Bloomberg. Experts said that with no historical precedent, they can’t fully explain the resurgence in infectious diseases. Jeremy Farrar, World Health Organization chief scientist, told The BMJ , “We’ve not had an acute, fast moving, and devastating pandemic in the modern scientific era. The last major devastating pandemic was in 1918 when …
Analysis reveals global post-covid surge in infectious diseases
Don’t Blame ‘Immunity Debt’ If You Get Sick This Winter
Don’t Blame ‘Immunity Debt’ If You Get Sick This Winter
Hi, it’s Immanual in New York. As respiratory illnesses spread across the US, an unfamiliar medical term has been cropping up in some media coverage. I’d like to tell you a little more about it, but first...
Don’t Blame ‘Immunity Debt’ If You Get Sick This Winter
Claims of an Immunity Debt in Children Owe Us Evidence
Claims of an Immunity Debt in Children Owe Us Evidence
At the beginning of the fifth season of the television show Buffy the Vampire Slayer, we the audience are introduced to a character, Dawn, we have never seen before. Intriguingly, every character
Claims of an Immunity Debt in Children Owe Us Evidence
There’s no such thing as a good cold
There’s no such thing as a good cold
“Immunity debt” can explain this year’s eye-popping cold and flu season — but it can also be dangerously misinterpreted.
There’s no such thing as a good cold
Not to be sneezed at: cardiovascular disease after COVID-19 infection
Not to be sneezed at: cardiovascular disease after COVID-19 infection
COVID-19 has changed our way of life since it was first identified in December of 2019. While our understanding of the manifestations and outcomes of the immediate acute illness has improved, we are still learning about the medium to long-term impact of this diagnosis on patients’ health. For some time, it has been suggested that COVID-19 may be associated with incident cardiovascular events such as venous thromboembolism, stroke and myocardial infarction.1 However, the absolute risk of these events and whether an excess risk is present are challenging to determine without a contemporary reference population. This is particularly problematic in the midst of a global pandemic. The UK Biobank is a large robust contemporary cohort of middle-aged volunteers who were prospectively recruited between 2006 and 2010.2 In this cohort, half a million participants aged between 40 and 69 years provided informed consent for detailed clinical assessment, with data linkage to routine data sources including primary care and death register data. Raisi-Estabragh and colleagues3 identified 20 505 participants from the UK Biobank study who had recorded COVID-19 infection status, defined based on disease coding in primary care or hospital episode statistics using a positive antibody test or a positive reverse transcriptase PCR based test. The authors included participants from the first two waves of the COVID-19 pandemic and were able to perform matched analysis in 17 871 participants. The authors used 1-to-2 propensity score matching to link to a reference population of 35 742 patients without evidence of COVID-19 infection using nearest neighbour matching and tying with the date of COVID-19 infection. Several relevant variables were included for matching including age, sex, deprivation, body mass index, ethnicity, diabetes mellitus, …
Not to be sneezed at: cardiovascular disease after COVID-19 infection
Long-term cardiovascular outcomes of COVID-19 - PubMed
Long-term cardiovascular outcomes of COVID-19 - PubMed
The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been comprehensively characterized. Here we used national healthcare databases from the US Department of Veterans Affairs to bui …
Long-term cardiovascular outcomes of COVID-19 - PubMed
What we now know about long COVID and our brains
What we now know about long COVID and our brains
After three years of the COVID-19 pandemic we know more about PCNS or Long COVID, but there’s a vital need for more research says University of Melbourne expert
What we now know about long COVID and our brains